# Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

> **NCT01248468** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 752 (actual)

## Conditions studied

- Pain, Migraine

## Interventions

- **DRUG:** Aspirin, acetaminophen and caffeine
- **DRUG:** Sumatriptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01248468
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 752 (ACTUAL)
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248468, "Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT01248468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*